Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BYHWT for Ischemic Stroke
NCT02150252Phase 2Unknown
- Sponsor
- China Medical University Hospital
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of buyang huanwu decoction in ischemic stroke (2 arms), sponsored by China Medical University Hospital. Primary endpoint: Gait parameters (Speed, Cadence, Strike length, Gait cycle, Double support) at 84 days. Status: unknown.
02
Drugs
buyang huanwu decoction
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02150252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150252.